Symbiotic Announces Instant Liquidity for Tokenized Assets: Midas is the First Issuer

The most capital-efficient liquidity sleeve for tokenized assets.

The RWA market crossed $25B on Ethereum this year. But if you hold a tokenized fund and want to exit, you're waiting 60 to 180 days for redemption. The asset is liquid in name. In practice, your capital is frozen.

This post will explain what Symbiotic Instant Liquidity is, how it fits within Midas' Open Liquidity Architecture, how Capital Facilities make it possible, and how the RFQ settlement layer works end to end. Once you understand these three things, you'll see why this is the most capital-efficient approach to RWA liquidity built onchain.

What Symbiotic builds

Symbiotic is set to launch a system to enable instant liquidity for Midas assets, starting with mGLOBAL and mF-ONE.

Holders will be able to redeem these assets instantly and atomically through an RFQ-based settlement layer, a solution within Midas’ Open Liquidity Architecture. No queue. No counterparty risk. No waiting.

The same system extends to lending market liquidations, with Redstone Settle integrated natively to facilitate settlement and execution, addressing what has historically been the weakest link in DeFi stacks built on tokenized assets.

What makes this different architecturally is that the capital settling redemptions isn’t pre-funded inventory sitting idle. It’s committed capital already serving a collateral function, now performing two roles simultaneously. That’s what makes it one of the most capital-efficient approaches to RWA liquidity built onchain.

The problem with how liquidity works today

Most attempts at RWA liquidity follow the same model: a market maker pre-funds a pool, sits on inventory, and hopes the spread covers the duration risk. That works for liquid assets. For tokenized funds with 60 to 180 day redemption windows, it doesn't. The capital cost of holding that inventory is too high. Market makers either don't show up, or they price the spread wide enough to make redemptions economically painful.

The result is a liquidity market that exists on paper but doesn't function in practice. Assets are technically redeemable. They're not practically liquid.

Capital Facilities

Capital Facilities are the core primitive that makes Instant Liquidity work differently.

Before Core V2, committed capital in Symbiotic vaults had one job: sit and wait. It was locked as collateral between obligation events and couldn't be deployed without losing its enforcement function. That was the tradeoff: you could have productive capital or enforceable collateral, not both.

Capital Facilities remove that trade-off. Committed capital can be deployed into whitelisted DeFi protocols (e.g., Morpho and Euler) between settlement events, where it continues to earn yield. When an obligation is triggered, the capital is automatically recalled, all while remaining fully enforceable as collateral for economic guarantees across Symbiotic’s natively integrated applications.

This is what funds the liquidity sleeve. The USDC backing redemptions isn't sitting in a pool waiting to be used. It's deployed and productive right up until the moment a redemption is requested. That's a fundamentally different capital structure than anything that existed before.

The RFQ settlement layer

The settlement side works through an onchain RFQ system.

Here's the full flow:

• An asset manager requests a redemption through the Symbiotic Swap UI
• Qualified market makers receive the request and submit bids
• The best bid executes in a single transaction
• The Market Maker Symbiotic Contract pulls the required USDC from the vault
• The asset manager sends the RWA to the Symbiotic contract
• USDC is released to the asset manager atomically
• The market maker earns the spread: no upfront capital required

At that point the market maker holds the RWA. They have two options: acquire it into their own portfolio and take the duration risk, or redeem it with the issuer. While the redemption processes, the RWA continues earning its intrinsic yield. The market maker is compensated for the wait.

Market makers can participate in two ways. They can become a Symbiotic vault curator directly, which gives them more flexibility over deployment parameters. Or they can work with an existing curator, subject to that curator's constraints. Either way, the system is open to any qualified market maker.

Why Midas

Midas raised a $50M Series A specifically to build an Open Liquidity Architecture for onchain investment products. Their tokenised investment strategies -- tokens with native DeFi composability across protocols like Morpho and Pendle -- made them the right first partner. The problem they were solving for their users maps directly to what Instant Liquidity enables. Holders of institutional-grade tokenized products shouldn't have to choose between quality and liquidity.

Built through the cycle, with an imminent launch

This didn't come together overnight. Instant Liquidity is the result of a lot of people building through a market that wasn't paying attention, solving a problem that was always real even when the hype wasn't there.

The full stack that makes this work: Fasanara as the asset manager behind mGLOBAL. Morpho and Euler as the yield sources for idle committed capital between settlement events. Keyring and Term Finance as launch partners.

Collateral markets is the category. Instant Liquidity is the product. Any issuer can integrate. Any market maker can participate.